CMS emailed providers last week with apricing listfor COVID-19 diagnostic tests. The list stated that laboratories testing patients for the novel coronavirus using the CDC’s test will receive about $36 in Medicare reimbursement, while those non-CDC test kits will receive about ...
Conclusions Our analyses provide an estimate of the scale of economic impacts of the COVID‐19 pandemic. These findings warrant consideration for policymaker relief and future redesign of emergency care financing. Ultimately, the COVID‐19 pandemic likely expanded known cracks in the financing of ...
An employer may exclude certain medical expenses even though the expenses are qualified by the IRS. An employer’s list of reimbursable medical expenses will be outlined in its HRA plan document for employees. The IRS issued a statement notifying taxpayers that at-home COVID-19 tests and persona...
The National Healthcare Security Administration said on Wednesday that all domestic COVID-19 medicines have been added to the national medical reimbursement list. Two newly approved homegrown pills — Xiannuoxin made by Simcere Pharmaceutical Group, and VV116 developed by Shanghai Vinnerna Biosciences ...
Gilead Sciences Korea said its Covid-19 treatment, Veklury (ingredient: remdesivir), will be covered under the national health insurance system starting from Oct. 25.Veklury is a direct-acting antiviral agent that inhibits viral RNA synthesis.The coverag
As many patients tried to limit trips to the pharmacy during the COVID-19 pandemic, an increase in 90-day prescriptions presented new challenges for pharmacies. Lennartz said these prescriptions can often result in underwater reimbursements, in which the pharmacy actually loses money. Fewer ...
DeLeo:Let's get started. Before the COVID-19 pandemic, telemedicine was largely underutilized in dermatology. What were some of the pitfalls that kept it from being more widely instrumental at that time? SUGGESTED for you Han:That's a very interesting question because I think it's a rather...
CMS is requiring all providers who furnish COVID-19 diagnostic tests to publicize their cash prices online. Providers who are non-compliant could face civil monetary penalties, the agency warns in the rule. The rule also states that out-of-network rates for patients who are vacci...
LONGMONT, Colo. (CBS4) -A new antiviral pill for treating COVID-19 could play a key part in moving past the pandemic, but some pharmacists won't carry it. That's because some are getting paid as little as $1 to give it out. ...
BEIJING, March 30 (Xinhua) -- Medical bills for the treatment of COVID-19 will be reimbursed by China's health insurance fund in the same manner as other Class B infectious diseases, according to a circular released by Chinese authorities on Thursday. ...